Trial Profile
A Phase 1 Study To Evaluate The Metabolism And Excretion Of [14C] PF-00868554 In Healthy Adult Male Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Dec 2009
Price :
$35
*
At a glance
- Drugs Filibuvir (Primary)
- Indications Hepatitis C
- Focus Pharmacokinetics
- Sponsors Pfizer
- 06 Mar 2009 Actual patient number (7) added as reported by ClinicalTrials.gov.
- 06 Mar 2009 Actual end date (Feb 2009) added as reported by ClinicalTrials.gov.
- 06 Mar 2009 Actual initiation date changed from Feb 2009 to Jan 2009 as reported by ClinicalTrials.gov.